Surrey Heartlands

Joint Formulary & PAD

Ferric maltol - Iron-deficiency anaemia

You are here : Home > Formulary Search > Ferric maltol - Iron-deficiency anaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important

Ferric Maltol 30mg capsules – reserved as a last option before referral and if parenteral iron is being considered

Documentation

Guidelines (Local)
Iron Deficiency Anaemia - Management Guidelines for Primary Care Oct 22
Evidence Review
Ferric Maltol (Feraccru) - Evidence Summary - ESHUT Oct 2017

PAD Profile

ChemicalSubstance :
Ferric maltol
Indication :
Iron-deficiency anaemia
Group Name :
Keywords :
Iron deficiency anaemia, IDA, iron supplements, iron supplementation, iron replacement therapy
Brand Names Include :
Feraccru
Important Information :
Latest Additions Date From :
Latest Additions Date To :
01 May 2025
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Ferric maltol is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Iron-deficiency anaemia.

Committee Recommendations (2)

07 Dec 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the following traffic lights status for iron preparations for iron deficiency anaemia as follows:

GREEN traffic light status - preferred
•    Ferrous Sulfate 200mg tablets
•    Ferrous Fumerate 210mg tablets
•    Ferrous Gluconate 300mg tablets

GREEN
•    Sodium Feredetate liquid – where a liquid is needed

GREEN
•    Ferric Maltol 30mg capsules – reserved as a last option before referral and if parenteral iron is being considered

11 Oct 17 - Epsom St Helier NDAIG
SDCCG and EPSOM ST HELIER - RED STATUS

The New Drugs & Interface Committee agreed that Ferracru (Ferric maltol) is available to be prescribed in the Trust by consultant gastroenterologists (or gastroenterology Specialist registrars under the guidance of gastro consultants) in IBD patients only. It has a place as an oral iron therapy in patients intolerant to at least one oral ferrous iron salt as an alternative to iv iron therapy. It is usually prescribed for 2-3 months from secondary care